BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Si Y, Xu Y, Guan J, Chen K, Kim S, Yang ES, Zhou L, Liu XM. Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy. Eng Life Sci 2021;21:37-44. [PMID: 33531889 DOI: 10.1002/elsc.202000027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen K, Si Y, Ou J, Guan JS, Kim S, Ernst P, Zhang Y, Zhou L, Han X, Liu XM. Antibody-Drug Conjugate to Treat Meningiomas. Pharmaceuticals (Basel) 2021;14:427. [PMID: 34063284 DOI: 10.3390/ph14050427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Si Y, Zhang Y, Ngo HG, Guan JS, Chen K, Wang Q, Singh AP, Xu Y, Zhou L, Yang ES, Liu XM. Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer. Cancers (Basel) 2021;13:3749. [PMID: 34359650 DOI: 10.3390/cancers13153749] [Reference Citation Analysis]
3 Yadav A, Singh S, Sohi H, Dang S. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment. AAPS PharmSciTech 2021;23:25. [PMID: 34907501 DOI: 10.1208/s12249-021-02174-9] [Reference Citation Analysis]
4 Si Y, Zhang Y, Guan JS, Ngo HG, Totoro A, Singh AP, Chen K, Xu Y, Yang ES, Zhou L, Liu R, Liu XM. Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines (Basel) 2021;9:882. [PMID: 34452008 DOI: 10.3390/vaccines9080882] [Reference Citation Analysis]
5 Kwon YM, Kim SH, Jung YS, Kwak JH. Synthesis and Biological Evaluation of (S)-2-(Substituted arylmethyl)-1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide Analogs and Their Synergistic Effect against PTEN-Deficient MDA-MB-468 Cells. Pharmaceuticals (Basel) 2021;14:974. [PMID: 34681198 DOI: 10.3390/ph14100974] [Reference Citation Analysis]
6 Chen K, Si Y, Guan J, Zhou Z, Kim S, Kim T, Shan L, Willey CD, Zhou L, Liu X. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines 2022;10:130. [DOI: 10.3390/biomedicines10010130] [Reference Citation Analysis]